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Abstract
Purpose: Causes of racial disparities in colorectal cancer
(CRC) screening may extend beyond individual-level character-
istics. We examined how physician density, beyond socioeco-
nomic factors, affected observed racial disadvantages in recent
CRC screening for blacks and Hispanics.
Methods: We obtained socioeconomic and CRC screening in-
formation on adults age  50 years from the Behavioral Risk Factor
Surveillance System (1997 to 2008) and information on the number
of primary care physicians and gastroenterologists from the Amer-
ican Medical Association Masterfile (1997 to 2008). We used fixed-
effect multivariate logistic regression to model the probability of
receiving a fecal occult blood test within the past year or endoscopic
screening within the past 5 years as a function of individual-level
socioeconomic factors and state-level physician supply.
Results: In 2008, 60.6% of whites were current on CRC
screening (95% CI, 60.6% to 61.0%) compared with 57.9% of
blacks (95% CI, 56.7% to 59.2%) and 42.9% of Hispanics
(95% CI, 41.0% to 44.8%). Inclusion of socioeconomic vari-
ables reversed black-white disparities (odds ratio [OR], 1.17;
95% CI, 1.15 to 1.19) but did not explain disadvantage for
Hispanics (OR, 0.89; 95% CI, 0.87 to 0.92). Once interaction
of race and physician supply was considered, likelihood of
recent CRC screening became statistically indistinguishable
for Hispanics and whites of similar socioeconomic status re-
siding in states with high physician supplies.
Conclusion: Socioeconomic factors and physician supply
are key predictors of CRC screening. Adjustment for socio-
economic determinants explained black-white disparities; fur-
ther adjustment for physician supply explained Hispanic-white
disparities. Physician distribution is a potentially remediable
contributor to ethnic/racial disparities in CRC screening.
Whether the United States is able to equitably meet future
demand for screening may depend on access, physician sup-
ply, and organization of the health care system.
Introduction
Colorectal cancer (CRC) screening prevents CRC and deaths
resulting from CRC by detecting and removing precancerous polyps
and identifying early-stage cancers. Despite its net benefits, CRC
screening in the United States remains low1,2 and below the uptake of
other evidence-based cancer screening tests.3 Over the last decade, ap-
proximately 50% of adults age  50 years underwent CRC screening
within recommended time intervals,4-7 and the screening rate is even
lower among racial and ethnic minorities.4,8-10 In 2008, for example,
57% of non-Hispanic whites were up to date on CRC screening, yet
the proportion was only 51% for non-Hispanic blacks and 39% for
Hispanics, according to analyses of the National Health Interview
Survey.11
In studies of both pre-Medicare and Medicare-eligible pop-
ulations, education, income, and insurance have been proven to
be important socioeconomic determinants of screening pat-
terns among racial groups over time.3,8,12-15 However, the
causes of racial disparities in CRC screening may extend beyond
individual-level characteristics. Place of residence may also serve
as a key factor in whether an individual receives timely and
appropriate screening. The impact of geographic location may
result, in part, from both generalist and specialist physician
supplies.16-19 However, the degree to which observed racial dis-
parities in CRC screening are associated with physician supply,
after adjusting for known socioeconomic determinants, re-
mains an open question.
In this study, we simultaneously examined both individual-
level socioeconomic determinants and state-level generalist and
specialist physician capacities that may affect racial disparities in
screening, both stool based and endoscopic. Our study spanned
1997 to 2008, a time range that includes the Medicare coverage
of fecal occult blood testing (FOBT) in 1998 and colonoscopy
in 2001 for average-risk beneficiaries. We examined how phy-
sician density, beyond socioeconomic factors, affected observed




Individual level. We collected socioeconomic, behavioral,
health, and CRC screening information on adults age  50
years using the Behavioral Risk Factor Surveillance System,
managed by the Centers for Disease Control and Prevention.
This system is a national telephone-based survey that collects
detailed demographic and household information on the health
of a representative sample of community-dwelling adults age
 50 years in the United States. Pertinent information includes
year, state, age, sex, race, Hispanic origin, income, educational
attainment, health insurance status, marital status, smoking sta-
tus, obesity status, home-based FOBT history, and endoscopic
screening history (which combines sigmoidoscopy and colono-
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scopy). Nationwide survey questions on both stool-based and
endoscopic CRC cancer screening (except in Connecticut,
Arizona, Illinois, and Tennessee) began in 1997 and were
also asked in 1999, 2001, 2002, 2004, 2006, and 2008.
Home-based FOBT was considered recent if it occurred
within the past year, and endoscopic screening (either flexi-
ble sigmoidoscopy or colonoscopy) was considered recent if
it occurred within the past 5 years. (Current US Preventive
Services Task Force guidelines recommend colorectal cancer
screening by one of the following modalities: annual FOBT,
decennial colonoscopy, or quinquennial flexible sigmoidos-
copy plus interval FOBT). The total number of survey re-
spondents was 816,881.
Physician density. We used the physician characteristics and
distribution information in US reports derived from the
American Medical Association Masterfile to estimate the to-
tal number of primary care physicians (PCPs) in clinical
practice and total number of gastroenterologists (GIs) in
clinical practice by state and year. We considered PCPs who
designated their specialty as general internal medicine, fam-
ily practice/general practice, and gerontology. We estimated
the number of adults age  50 years from decennial census
counts and annual intercensal estimates of the resident pop-
ulation by state and year.
Statistical Analyses
Using fixed-effect multivariate logistic regression, we modeled
the probabilities of either receiving FOBT within the past year
or endoscopic screening within the past 5 years as a function of
the individual-level covariates (age, sex, race, ethnicity, educa-
tional attainment, income level, marital status, smoking status,
obesity status, health insurance coverage) and state-level cova-
riates (PCP and GI densities). Hereafter, we refer to non-His-
panic whites as whites, non-Hispanic blacks as blacks, and other
non-Hispanics as others.
We used R version 2.9.2 (R Project for Statistical Comput-
ing; http://www.r-project.org) for all statistical analyses. The
Dartmouth College and Dartmouth-Hitchcock Medical Cen-
ter Committee for the Protection of Human Subjects deter-




Appendix Table A1 (online only) lists individual-level char-
acteristics of the study population in relation to CRC screening.
The proportion of adults receiving recent CRC screening grew
over time from 38.7% in 1997 (95% CI, 38% to 39.4%) to
55.9% in 2008 (95% CI, 55.6% to 56.2%). Over the entire
study period, women were more likely to be up to date for CRC
screening: 49.4% (95% CI, 49.2% to 49.6%) compared with
47.5% for men (95% CI, 47.3% to 47.7%). Whites were also
more likely to be up to date compared with blacks and Hispan-
ics: 50% (95% CI, 49.9% to 50.2%) versus 46.8% (46.2% to
47.4%) and 36.8% (95% CI, 36.1% to 37.6%), respectively.
The proportion of up-to-date adults peaked among those age
70 to 74 years at 56.6% (95% CI, 56.2% to 57%). We also
observed an education and income gradient. Finally, the pro-
portion of adults up to date on CRC screening was higher for
those with health insurance compared with those without:
50.4% (95% CI, 50.2% to 50.5%) versus 23.9% (95% CI,
23.3% to 24.6%).
Figure 1 presents the relationship between state-level PCP
and GI densities in 2008, along with their marginal distribu-
tions. Higher PCP density was associated with higher GI den-
sity (r  0.63). Analyses of earlier years revealed similar patterns
of PCP and GI densities (data not shown).
Temporal Patterns in Recent CRC Screening
Figure 2 depicts temporal patterns in recent CRC screening.
The proportion of adults age  50 years receiving CRC screen-
ing generally increased through the study period for all racial/
ethnic groups. The method of screening changed over time,
with endoscopic screening increasing and FOBT screening de-
creasing. Although whites, blacks, and Hispanics experienced
similar temporal patterns, levels of screening differed. In 2008,
for example, 60.6% of whites were up to date on CRC screen-
ing (95% CI, 60.6% to 61.0%) compared with 57.9% of blacks
(95% CI, 56.7% to 59.2%) and 42.9% of Hispanics (95% CI,
41.0% to 44.8%).
FOBT Within Past Year or Endoscopic Screening
Within Past 5 Years
Appendix Table A2 (online only) summarizes results of nested
logistic regression models for undergoing either FOBT within
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Figure 1. State-level primary care physician (PCP) and gastroenterol-
ogist (GI) densities (physicians per million adults age  50 years) in the
year 2008. Each state is labeled with its two-letter abbreviation. Mar-
ginal distributions of PCP and GI densities shown as histograms.
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recent FOBT or endoscopic screening). In the baseline model
(model one), we adjusted for time, age, sex, and race/ethnicity
and observed that blacks (odds ratio [OR], 0.93; 95% CI, 0.92
to 0.95) and Hispanics (OR, 0.69; 95% CI, 0.67 to 0.70) were
less likely to undergo recent FOBT or endoscopic screening
compared with their white counterparts. In model two, the
inclusion of socioeconomic and health variables reversed black-
white disparities (OR, 1.17; 95% CI, 1.15 to 1.19) but did not
eliminate disparities among Hispanics (OR, 0.89; 95% CI,
0.87 to 0.92). In model three, we further adjusted for physician
density and observed a positive gradient between the supply of
GIs (GI density) and the likelihood of recent screening (OR,
1.009; 95% CI, 1.007 to 1.01). Finally, in model four, we
considered the interaction of physician density and race to ex-
amine whether the effect of physician density on recent screen-
ing varied by race. We observed a positive and statistically
significant interaction term for GI density and Hispanic race/
ethnicity, indicating that greater GI density had a larger effect
among Hispanics. For blacks, we did not observe any additional
impact of greater physician density on recent CRC screening
compared with that observed for whites.
Figure 3 depicts this interaction effect by computing the
predicted probability of recent CRC screening by GI density
and race. All other covariates are set at their modal values (year
2008, age 65 to 70 years, female sex, at least some college, not
obese, nonsmoker, married, income  $50,000, health insur-
ance). At the 10th percentile of GI density (70 GIs per million
adults age  50 years), the probability of recent CRC screening
was 66.7% for Hispanics (95% CI, 65.9% to 67.5%), 70.2%
for whites (95% CI, 69.8% to 70.6%), and 73.4% for blacks
(95% CI, 72.7% to 74.1%). For all three racial/ethnic groups,
the probability of recent CRC screening increased as GI density
increased. The pace of increase was highest for Hispanics. At the
85th percentile of GI density (140 GIs per million adults age
 50 years) and higher, the probability of recent screening was
indistinguishable between whites and Hispanics although still
higher for blacks. For example, at a GI density of 170 per
million adults age  50 years, the probability of recent CRC
screening was 72.2% for Hispanics (95% CI, 71.0% to 73.3%),
71.7% for whites (95% CI, 71.3% to 72.1%), and 74.5% for
blacks (95% CI, 73.6% to 75.4%).
Finally, we considered the effect of health insurance on pre–
Medicare-age adults 50 to 64 years old (Appendix Table A3,
online only). Setting all other covariates at their modal values
(ie, year 2008, age 65 to 70 years, female sex, at least some
college, not obese, nonsmoker, married, income  $50,000,
health insurance) and GI and PCP densities at their median
values, the probability of recent CRC screening was higher for
those with health insurance compared with those without for all
three racial/ethnic groups. The probability equaled 59.6% for
whites with health insurance (95% CI, 59.2% to 59.8%) and
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Figure 3. Predicted probability of recent colorectal cancer screening by
racial/ethnic group and gastroenterologist density. All other covariates
are set at their modal values (year 2008, age 65 to 70 years, female sex,
at least some college, not obese, nonsmoker, married, income
 $50,000, health insurance). Solid circles represent the median pre-
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Figure 2. Proportion of adults age  50 years undergoing only fecal occult blood testing (FOBT) within the past year, only endoscopic screening within
the past 5 years, and both FOBT within the past year and endoscopic screening within past 5 years.
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37.2% for those without (95% CI, 36.7% to 37.8%), 63.0%
for blacks with health insurance (95% CI, 62.4% to 63.5%)
and 40.7% for those without (95% CI, 40.0% to 41.4%), and
57.2% for Hispanics with health insurance (95% CI, 56.5% to
58.0%) and 35.0% for those without (95% CI, 34.2% to
35.8%).
Discussion
This study has two main findings. First, socioeconomic deter-
minants and physician density are key predictors of CRC
screening. This result confirms previous findings in the lit-
erature.4,5,11,12,20 Second, adjustment for socioeconomic de-
terminants eliminated black-white disparities, and further
adjustment for physician density eliminated Hispanic-white dis-
parities. Previous research on race and CRC screening has primar-
ily focused on black-white disparities. Here, we also considered
Hispanic-white disparities, an important undertaking given the
Hispanic population is projected to steadily rise to 20% of the total
US population in the next 20 years.21
For both FOBT and endoscopic screening, socioeconomic
status has been previously observed to mostly or fully account
for observed black-white racial disparities.3,8,15 Socioeconomic
factors such as income, educational attainment, occupation,
and health insurance directly affect an individual’s access and
utilization of screening, the quality of screening, and the poten-
tial benefits derived from screening. We reached similar conclu-
sions for the black-white disparity in recent CRC screening. Yet
for Hispanics, these socioeconomic factors explain some, al-
though not all, of the observed disparities. Higher densities of
GIs may be especially important for Hispanics. Further work is
needed to determine if these effects are causal and, if so, why
Hispanics are particularly sensitive to GI physician density.
In addition to health care access and usage, the supply and
balance of PCPs and GIs have an important effect on CRC
screening, detection, and survival. PCPs serve an important role
in initiating and overseeing CRC cancer screening.22,23 Over
time, colonoscopy has become the more favored method of
endoscopic screening compared with sigmoidoscopy. GIs per-
form two thirds of these procedures,24,25 so it is logical that GI
density will affect screening rates. Our results suggest higher GI
density may be especially important to higher overall CRC
screening and reductions in some disparities. PCP density is
also likely important, although its effect may be masked by
regional socioeconomic factors and GI density, with which it is
correlated. Beyond screening, CRC incidence, late-stage diag-
nosis, and mortality decreased as PCP and GI densities in-
creased in studies conducted in Florida26,27 and Pennsylvania.28
Similar benefits of high PCP and specialist physician density
have been noted in breast cancer,29,30 urologic cancer,31 and
melanoma.32
Policy initiatives at the community, state, and national levels
have attempted to increase access and physician supply as well as
reduce financial, physical, institutional, and organizational bar-
riers. Medicare coverage of annual FOBT and quadrennial sig-
moidoscopy began in 1998, and coverage for decennial
colonoscopy began in 2001 for average-risk beneficiaries. Re-
sults of these initiatives have varied, disparities have per-
sisted,12,13 and modest improvements in screening have been
observed most often in the highest socioeconomic groups.33
We acknowledge several limitations in this study. First, we
were not able to differentiate between sigmoidoscopy and
colonoscopy for the entire time period between 1993 and 2008.
Current US Preventive Services Task Force guidelines for en-
doscopic CRC screening recommend sigmoidoscopy every 5
years or colonoscopy every 10 years for average-risk adults age
50 to 75 years. In considering flexible sigmoidoscopy or colono-
scopy within the past 5 years, we may have provided conserva-
tive estimates of recent endoscopic screening. Second, we were
not able to determine whether the underlying purpose of an
individual’s endoscopic CRC procedure was screening, diagno-
sis, or surveillance. In 2008, for example, 40.3% of the adults
reporting FOBT within the past year also reported colonoscopy
within the past year. Many of these colonoscopies were likely
conducted to investigate a positive FOBT result for diagnostic
purposes rather than screening. However, our outcome of in-
terest was recent CRC screening, which occurred with the re-
cent FOBT. Third, we relied on self-reported CRC cancer
screening, which may be subject to recall bias. Fourth, we were
not able to differentiate the type of health insurance carried by
respondents. Fifth, reporting lags and other inaccuracies have
been identified with the American Medical Association Master-
file, which may have affected our knowledge of physician den-
sity levels and the geographic and specialty distributions of the
physician workforce.34,35 We may also have underestimated the
universe of physicians conducting CRC screening by excluding
colon and rectal and general surgeons, some of whom perform
screening colonoscopy, and overestimated by including all GIs,
including those who do not perform lower endoscopy. Sixth,
we did not measure the productivity or number of hours spent
on patient care among clinical PCPs and GIs. We treated a state
as a unit, yet considerable variation exists within states in the
distribution of PCPs and GIs as well as CRC screening levels.
Additional physicians in a state may locate in areas where den-
sity is already high, and diffusion of care may be limited. Addi-
tional analysis at the local or regional health care market level
may allow greater understanding of physician supply and utili-
zation of colorectal cancer screening. Finally, the associations
we observed may not reflect direct causation.
Future work could expand on this analysis of the joint rela-
tionship between individual-level socioeconomic determinants
and area-level physician capacity and effect on CRC screening.
Focus on smaller geographic areas (eg, hospital referral regions)
and more refined calculation of physician capacity (eg, based on
full-time equivalents of clinical work) would enable a more
nuanced understanding of how local supply might best meet
local demand. Additional work could also examine the current
distribution of specialist physicians who perform screening
colonoscopy (GIs, colon and rectal surgeons, and general sur-
geons) to determine if future capacity will be able to meet future
demand.
As the population ages, and as the modality of screening
changes, the demand for CRC cancer screening will likely in-
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crease faster than the capacity to perform that screening. First,
the proportion of adults age  50 years is projected to increase
by approximately 24% over the next 20 years,36 which may far
exceed the rate of growth in physicians.37,37 Second, PCPs serve
an important role in initiating and overseeing CRC cancer
screening,22,38 and great regional shortages of PCPs currently
exist or are anticipated. Third, colonoscopy has become the
more favored method of endoscopic screening compared with
sigmoidoscopy,39 and GIs—also in limited and variable sup-
ply—perform the vast majority of these procedures.24,25
Whether the United States is able to meet the future demand
for screening and address historical disparities in screening may
depend on access, physician supply, interaction of PCPs and
specialists, financial reimbursement of services, and organiza-
tion of the health care system.
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Appendix
Table A1. Distribution of Demographic and Socioeconomic Characteristics of Study Population
Characteristic
FOBT Within Past 1 Year or Endoscopic Screening Within Past 5 Years
No. % 95% CI
Total 415,080 48.4 48.2 to 48.5
Year
1997 18,098 38.7 38.0 to 39.4
1999 23,835 41.8 41.1 to 42.4
2001 36,918 46.6 46.1 to 47.1
2002 48,475 48.7 48.3 to 49.2
2004 67,433 50.8 50.4 to 51.2
2006 92,805 52.9 52.6 to 53.2
2008 127,516 55.9 55.6 to 56.2
Sex
Male 255,174 47.5 47.3 to 47.7
Female 159,906 49.4 49.2 to 49.6
Race/ethnicity
White, non-Hispanic 356,092 50 49.9 to 50.2
Black, non-Hispanic 30,391 46.8 46.2 to 47.4
Hispanic 15,046 36.8 36.1 to 37.6
Other, non-Hispanic 19,518 42.7 42.0 to 43.4
Age group, years
50-54 60,348 35.8 35.5 to 36.2
55-59 70,845 46.6 46.2 to 46.9
60-64 67,776 51.5 51.2 to 51.9
65-69 64,946 55 54.6 to 55.4
70-74 58,128 56.6 56.2 to 57.0
75-79 47,605 56.5 56.1 to 56.9
80-84 30,325 52.4 51.8 to 53.0
 85 15,107 42 41.2 to 42.8
Education
Less than high school 46,935 38 37.6 to 38.5
High school graduate 130,047 45.7 45.4 to 45.9
At least some college 239,568 53.1 52.9 to 53.3
Annual household income
 $25,000 109,885 42.3 42.0 to 42.6
$25,0000-$49,999 107,259 49 48.7 to 49.3
 $50,000 197,942 51.5 51.3 to 51.7
Marital status
Married 239,183 50.7 50.5 to 50.9
Separated/divorced 67,912 41.7 41.3 to 42.0
Single 24,396 40.5 39.9 to 41.1
Widowed 95,733 47.2 46.9 to 47.5
Obese
No 314,190 48.8 48.7 to 49.0
Yes 114,667 49.1 48.9 to 49.4
Continued on next page
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Table A1. (Continued)
Characteristic
FOBT Within Past 1 Year or Endoscopic Screening Within Past 5 Years
No. % 95% CI
Current smoker
No 201,781 48.2 48.0 to 48.4
Yes 214,841 48.5 48.3 to 48.7
Health insurance
No 15,909 23.9 23.3 to 24.6
Yes 399,655 50.4 50.2 to 50.5
Abbreviation: FOBT, fecal occult blood testing.
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Table A2. Nested Logistic Regression Model Results for Recent Colorectal Cancer Screening
Parameter
Model 1 Model 2 Model 3 Model 4
 95% CI  95% CI  95% CI  95% CI
Intercept 1.07 1.091 to 1.048 1.931 1.963 to 1.899 1.708 1.745 to 1.671 1.715 1.752 to 1.677
Year (ref: 1997)
1999 0.158 0.133 to 0.183 0.147 0.121 to 0.173 0.144 0.118 to 0.17 0.144 0.118 to 0.17
2001 0.425 0.401 to 0.448 0.395 0.371 to 0.42 0.394 0.37 to 0.419 0.394 0.37 to 0.419
2002 0.475 0.453 to 0.498 0.445 0.421 to 0.468 0.45 0.426 to 0.473 0.45 0.427 to 0.474
2004 0.598 0.577 to 0.62 0.561 0.538 to 0.583 0.564 0.542 to 0.587 0.565 0.542 to 0.588
2006 0.689 0.668 to 0.71 0.639 0.617 to 0.661 0.632 0.61 to 0.654 0.632 0.61 to 0.654
2008 0.806 0.786 to 0.827 0.746 0.725 to 0.768 0.736 0.714 to 0.757 0.736 0.715 to 0.758
Age, years (ref: 50-54)
55-59 0.444 0.43 to 0.459 0.473 0.457 to 0.488 0.473 0.457 to 0.488 0.473 0.457 to 0.488
60-64 0.64 0.625 to 0.655 0.714 0.698 to 0.73 0.714 0.698 to 0.73 0.714 0.698 to 0.73
65-69 0.799 0.784 to 0.815 0.848 0.831 to 0.865 0.849 0.832 to 0.865 0.849 0.832 to 0.866
70-74 0.88 0.864 to 0.897 0.969 0.952 to 0.987 0.969 0.951 to 0.987 0.97 0.952 to 0.987
75-79 0.826 0.808 to 0.843 0.956 0.937 to 0.975 0.955 0.936 to 0.974 0.955 0.936 to 0.974
80-84 0.607 0.587 to 0.626 0.779 0.757 to 0.801 0.777 0.756 to 0.799 0.778 0.756 to 0.8
 85 0.192 0.168 to 0.216 0.411 0.384 to 0.438 0.409 0.383 to 0.436 0.409 0.383 to 0.436
Male sex (ref: female) 0.083 0.074 to 0.092 0.01 0 to 0.02 0.01 0 to 0.02 0.01 0 to 0.02
Race/ethnicity (ref: white,
non-Hispanic)
Black, non-Hispanic 0.071 0.089 to 0.054 0.159 0.14 to 0.178 0.152 0.133 to 0.17 0.232 0.151 to 0.313
Hispanic 0.374 0.397 to 0.35 0.113 0.138 to 0.087 0.095 0.121 to 0.07 0.062 0.155 to 0.032
Other, non-Hispanic 0.263 0.284 to 0.242 0.182 0.204 to 0.16 0.179 0.201 to 0.157 0.143 0.238 to 0.048
Education (ref, HS graduate)
Less than HS graduate 0.216 0.232 to 0.201 0.216 0.232 to 0.201 0.217 0.232 to 0.201
Some college 0.27 0.259 to 0.281 0.272 0.262 to 0.283 0.272 0.262 to 0.283
Obese (ref: not obese) 0.076 0.065 to 0.087 0.075 0.064 to 0.086 0.075 0.064 to 0.085
Marital status (ref: married)
Separated/divorced 0.21 0.223 to 0.197 0.21 0.224 to 0.197 0.211 0.224 to 0.197
Single 0.276 0.297 to 0.255 0.28 0.301 to 0.259 0.28 0.301 to 0.259
Widowed 0.207 0.22 to 0.193 0.207 0.221 to 0.194 0.207 0.221 to 0.194
Income (ref: $25,000-
$50,000)
 $50,000 0.078 0.066 to 0.089 0.077 0.065 to 0.088 0.077 0.065 to 0.088
 $25,000 0.12 0.133 to 0.107 0.119 0.133 to 0.106 0.119 0.133 to 0.106
Smoker (ref: nonsmoker) 0.016 0.007 to 0.026 0.016 0.007 to 0.026 0.016 0.007 to 0.026
Health insurance (ref: none) 0.866 0.846 to 0.887 0.862 0.841 to 0.883 0.862 0.841 to 0.883
Density*
PCP, units 100 0.012 0.013 to 0.011 0.012 0.013 to 0.01
GI, units 10 0.009 0.007 to 0.01 0.008 0.006 to 0.01
Black, non-Hispanic  PCP 0.002 0.007 to 0.003
Hispanic  PCP 0.009 0.014 to 0.004
Other, non-Hispanic  PCP 0.001 0.007 to 0.004
Black, non-Hispanic  GI 0.002 0.009 to 0.006
Hispanic  GI 0.018 0.011 to 0.025
Other, non-Hispanic  GI 0 0.008 to 0.007
AIC 1,094,410 1,008,824 1,008,271 1,008,253
Residual deviance 1,094,374 1,008,768 1,008,211 1,008,181
df 812,089 764,685 764,683 764,677
Abbreviations: AIC, Akaike information criterion; GI, gastroenterologist; HS, high school; PCP, primary care physician; ref, reference.
* PCP density measured in units of 100 PCPs per million adults age  50 years; GI density measured in units of 10 GIs per million adults age  50 years.
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Table A3. Predicted Probability of Recent Colorectal Cancer Screening of Pre-Medicare Adults*
Racial/Ethnic Group
No Health Insurance Health Insurance
Point Estimate (%) 95% CI Point Estimate (%) 95% CI
Non-Hispanic white 37.3 36.3 to 37.8 59.9 59.2 to 59.9
Non-Hispanic black 40.7 39.9 to 41.3 63.0 62.5 to 63.5
Hispanic 35.0 34.3 to 35.8 57.2 56.5 to 58.0
* Age 50 to 64 years, by racial/ethnic group and health insurance status. All other covariates set at modal values (year 2008, age 65-70 years, female sex, at least some
college, not obese, nonsmoker, married, income  $50,000, 110 gastroenterologists per million adults age  50 years, 2,462 primary care physicians per million adults
age  50 years).
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